Trial Profile

A phase IIa clinical trial of Polyclonal antibody for Clostridium difficile infections

Status: Planning

Phase of Trial: Phase II

Latest Information Update: 24 Jul 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

24 Jul 2025 New trial record
17 Jul 2025 According to MicroPharm media release, The Kenyan trial will be undertaken in Nairobi and led by clinicians from the University of Nairobi acting in conjunction with the University of Texas Health Science Center, Houston, USA. The Australian trial will be undertaken by clinicians at the Fiona Stanley Hospital, Perth.
17 Jul 2025 According to MicroPharm media release, the company has been awarded funding from Wellcome to undertake a Phase II clinical trial of an oral therapeutic (OraCAb) for the treatment of non-life-threatening C. difficile infection (CDI). MicroPharm will be the Sponsor of the multi-country trial with harmonised trial sites across Kenya and Australia to facilitate assessment of globally circulating C. diff. strains.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com